Intensity-Modulated Radiation Therapy (IMRT) in the Treatment of Non-Anaplastic Non-Medullary Thyroid Cancer

NCT01882816 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

27

Enrollment

OTHER

Sponsor class

Conditions

Thyroid Cancer

Interventions

RADIATION: IMRT
DEVICE: DWI MRI
DRUG: Doxorubicin
OTHER: Modified Barium Swallow Impairment Profile (MBSImP)

Sponsor

Memorial Sloan Kettering Cancer Center